Spontaneous intracerebral haemorrhages-warfarin as a risk factor.
The primary objective of this study was to evaluate the incidence of warfarin use in 156 consecutive patients presenting to a single tertiary referral centre with spontaneous intracerebral haemorrhage. Our study found that 11% of patients (16/159) presenting with spontaneous intracerebral haemorrhage were on warfarin for prophylactic anticoagulation at time of presentation. Comparison was made to other published Australian data with regard to the incidence of warfarin use in patients presenting with spontaneous intracerebral haemorrhage. Patient outcomes were also examined.
Lawrentschuk
Nathan
N
Department of Neurosurgery, Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Parkville, 3050, Victoria, Australia.
Kariappa
Sonia
S
Kaye
Andrew H
AH
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy; D001315:Australia; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000401:mortality / Q000601:surgery; D005260:Female; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D012189:Retrospective Studies; D012307:Risk Factors; D012984:Software; D014057:Tomography, X-Ray Computed; D014859:Warfarin / Q000009:adverse effects* / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin